Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.12
HawkEye 360 Secures $135M In New Global Contracts Since October 1
Benzinga
2026.11.12
Oppenheimer Maintains Outperform on McGrath RentCorp, Raises Price Target to $149
Benzinga
2026.11.12
LiveOne Q2 EPS $(0.37) Misses $(0.34) Estimate, Sales $17.966M Miss $19.901M Estimate
Benzinga
2026.11.12
Why Wall Street Won’t Pay $1 for this Stock Despite Its $439 Million in Ethereum
BeInCrypto
2026.11.12
Moderna Raises FY26 Sales Growth Guidance To 15%-25% From 10%; On Track To Achieve FY26 Gross Margin Expansion Of ~10 Percentage Points Excluding Litigation Settlement Charge; Expects Annual Cash Costs Of ~$4B-$4.5B Over 2027-2030; Sees Ending 2026 With...
Benzinga
2026.11.12
Jensen’s ‘Affair’ Wiped Out $300 Billion In Nvidia Market Value, Top Economist Says, as Market Concentration Is Highest ‘Since 1932’
Benzinga
2026.11.12
HC Wainwright & Co. Reiterates Buy on Coya Therapeutics, Maintains $18 Price Target
Benzinga
2026.11.12
What's Going On With Lithium Americas Stock Thursday?
Benzinga
2026.11.12
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
Benzinga
2026.11.12
Barclays Upgrades Reliance to Overweight, Raises Price Target to $507
Benzinga
2026.11.12
Wells Fargo Upgrades enGene Therapeutics to Overweight, Raises Price Target to $6
Benzinga
2026.11.12
HC Wainwright & Co. Maintains Buy on Abeona Therapeutics, Lowers Price Target to $18
Benzinga
2026.11.12
William Blair Upgrades Advanced Micro Devices to Outperform
Benzinga
2026.11.12
Twist Bioscience Q4 EPS $(0.32) Beats $(0.34) Estimate, Sales $126.644M Beat $123.085M Estimate
Benzinga
2026.11.12
Central Puerto Q3 EPS $0.25 Down From $0.70 YoY, Sales $532.400M Up From $233.900M YoY
Benzinga
2026.11.12
This Nvidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Benzinga
2026.11.12
Okeanis Eco Tankers Cashes In On Soaring Shipping Rates
Benzinga
2026.11.12
Jefferies Upgrades Pattern Group to Buy, Raises Price Target to $27
Benzinga
2026.11.12
Altimmune Publishes IMPACT Phase 2b 48-Week Data In The Lancet Gastroenterology & Hepatology
Benzinga
2026.11.12
Hydrofarm Holdings Regains Nasdaq Compliance
Benzinga
2026.11.12
Baird Maintains Outperform on Novanta, Lowers Price Target to $175
Benzinga
2026.11.12
Beamr Imaging Reports 9M Sales Of ~$1.38M; Reaffirms FY26 Sales Growth Guidance Of ~50%
Benzinga
2026.11.12
Nebius Group N.V. - Class A Ordinary Shares Q3 Adj. EPS $0.30 Beats $(0.69) Estimate, Sales $980.800M Beat $907.534M Estimate
Benzinga
2026.11.12
NervGen Says FDA Grants NVG-291 Breakthrough Therapy Designation For Treatment Of Chronic Traumatic Cervical Motor-Incomplete SCI
Benzinga
2026.11.12
Satellos Bioscience Q3 EPS $(0.53) Beats $(0.56) Estimate
Benzinga
2026.11.12
Lantronix Announces Strategic Partnership With Latent AI To Bring Automatic Target Recognition To Compact Robotics Platform Spotter
Benzinga
2026.11.12
Kardigan Q3 EPS $(0.64) Beats $(0.77) Estimate
Benzinga
2026.11.12
Criteo Included In MSCI Global Investable Market Indexes, Effective November 30
Benzinga
2026.11.12
Twist Bioscience Sees FY2027 Sales $550.000M-$560.000M vs $547.137M Est
Benzinga
2026.11.12
Baird Maintains Outperform on Terreno Realty, Lowers Price Target to $69
Benzinga
1
...
60
61
62
63
64
65
...
712
>